Literature DB >> 9853272

A simultaneous study of the metabolism of apolipoprotein B and albumin in nephrotic patients.

T Demant1, C Mathes, K Gütlich, A Bedynek, H B Steinhauer, T Bosch, C J Packard, G L Warwick.   

Abstract

BACKGROUND: The nephrotic syndrome is characterized by proteinuria, hypoalbuminemia and hyperlipidemia. Despite intensive research it is not clear at present what the causal links are between these pathological findings.
METHODS: Stable isotope labeled amino acid tracer kinetic analysis was used to simultaneously investigate the metabolism of four apolipoprotein B-containing lipoproteins (VLDL1, VLDL2, IDL and LDL) and albumin in seven patients with nephrotic syndrome and marked hypercholesterolemia, in two additional nephrotic patients with concomitant renal failure and mixed hyperlipidemia, and in a matched group of normolipidemic controls.
RESULTS: Increased concentrations of VLDL2, IDL and LDL were due to (a) impaired VLDL2 and IDL delipidation, (b) reduced LDL catabolism, and (c) a trend towards an increased rate of total apolipoprotein B production. The rate of fractional albumin elimination was three times higher in patients than in controls and the rate of albumin synthesis was increased by 45%. No correlations were detectable between rates of apolipoprotein B production and the rate of albumin synthesis.
CONCLUSIONS: The results of this study suggest that hyperlipidemia in nephrotic syndrome is predominantly the result of delayed lipoprotein delipidation and catabolism. There is no evidence that it is driven by a general increase of the rate of hepatic protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9853272     DOI: 10.1046/j.1523-1755.1998.00204.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  5 in total

1.  The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Nephrotic Syndrome-Associated Hypercholesterolemia.

Authors:  Mary E Haas; Amy E Levenson; Xiaowei Sun; Wan-Hui Liao; Joseph M Rutkowski; Sarah D de Ferranti; Valerie A Schumacher; Philipp E Scherer; David J Salant; Sudha B Biddinger
Journal:  Circulation       Date:  2016-07-05       Impact factor: 29.690

Review 2.  Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease.

Authors:  Mona Khurana; Douglas M Silverstein
Journal:  Pediatr Nephrol       Date:  2015-03-24       Impact factor: 3.714

Review 3.  Clinical Significance of Serum Albumin and Implications of FcRn Inhibitor Treatment in IgG-Mediated Autoimmune Disorders.

Authors:  E Sally Ward; Deborah Gelinas; Erwin Dreesen; Jolien Van Santbergen; Jan Terje Andersen; Nicholas J Silvestri; Joseph E Kiss; Darrell Sleep; Daniel J Rader; John J P Kastelein; Els Louagie; Gestur Vidarsson; Isabel Spriet
Journal:  Front Immunol       Date:  2022-06-01       Impact factor: 8.786

4.  Renal Function and Hematology in Rats with Congenital Renal Hypoplasia.

Authors:  Hidenori Yasuda; Kohei Amakasu; Yuki Tochigi; Kentaro Katayama; Hiroetsu Suzuki
Journal:  Comp Med       Date:  2016-02       Impact factor: 0.982

5.  Diagnostic markers based on a computational model of lipoprotein metabolism.

Authors:  Daniël B van Schalkwijk; Ben van Ommen; Andreas P Freidig; Jan van der Greef; Albert A de Graaf
Journal:  J Clin Bioinforma       Date:  2011-10-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.